Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 30, Issue 3, 2008, Pages 225-227

  Li, Jian ^a   Xu, Jian Ming ^a   Li, Jie ^a   Zhang, Xiao Dong ^a   Bai, Y ^a   Chu, Yu Ping ^a   Wang, Yong Hua ^a   Liu, Duan Qi ^a   Jin, Mao Lin ^a   Shen, Lin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IFL PROTOCOL; IRINOTECAN;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COLON TUMOR; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; NEUTROPENIA; PATHOLOGY; PROSPECTIVE STUDY; RECTUM TUMOR; REMISSION; SURVIVAL RATE; TUMOR RECURRENCE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE; VOMITING; YOUNG ADULT;

EID: 77951649719     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)